dpp-4 inhibitors vs. glp-1 agonist Comparison of receptor agonists and dpp-4_inhibitors [TUSOM | Pharmwiki]
Description
In an AD mouse model, liraglutide reduces the activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome in the microglia, leading to the decreased production of proinflammatory cytokines and A plaques [52]
![dpp-4 inhibitors vs. glp-1 agonist Comparison of receptor agonists and dpp-4_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b)
Diabetes, Metabolic Syndrome
![dpp-4 inhibitors vs. glp-1 agonist Comparison of receptor agonists and dpp-4_inhibitors [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41574-020-0399-8/MediaObjects/41574_2020_399_Fig1_HTML.png)
Survodutide is a novel dual-action drug designed to treat obesity and related metabolic conditions
![dpp-4 inhibitors vs. glp-1 agonist Comparison of receptor agonists and dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/265093827/figure/fig2/AS:271488230096906@1441739246158/Effect-of-DPP4-inhibition-on-venous-GLP-1-levels-at-baseline-and-during-the-maximum-dose.png)
The Physiology of Glucagon-Like Peptide 1
![dpp-4 inhibitors vs. glp-1 agonist Comparison of receptor agonists and dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.bmj.com/content/bmj/385/bmj-2023-078483/F1.medium.jpg)
Wanko said